News / 

Stocks positive...FBI blames North Korea for Sony hack...NLRB files complaint against McDonald's

By The Associated Press | Posted - Dec. 19, 2014 at 12:31 p.m.



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) — Major stock indexes are slightly higher in afternoon trading on Wall Street, adding to two days of big gains. The Standard & Poor's 500 index is on pace to close with its second-best weekly gain this year.

WASHINGTON (AP) — The FBI says it has enough evidence to conclude that North Korea was behind the hack attack against Sony Pictures Entertainment. The attack led to the disclosure of tens of thousands of company emails and other materials, and terrorist threats that prompted Sony to cancel the release of the movie "The Interview," about a plot to assassinate North Korea's leader. President Barack Obama says Sony "made a mistake" in deciding to shelve the film.

WASHINGTON (AP) — The National Labor Relations Board is filing a complaint against McDonald's and its franchisees over worker rights. The board says it has found 86 cases of unlawful conduct including action taken against workers who sought job improvements. McDonald's calls the move an "overreach" and plans to contest it. Hearings on the issue are set for March.

WASHINGTON (AP) — T-Mobile US will pay up to $90 million in refunds and fines for billing customers for cellphone text services they didn't order, under a settlement with federal regulators. The fourth-largest U.S. cellphone company was accused of billing customers for subscriptions to things like horoscopes or celebrity gossip updates.

WASHINGTON, D.C. (AP) — U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca's Lynparza. The drug is for women whose ovarian cancer is associated with certain defective genes and whose cancer persists after multiple treatments. The Food and Drug Administration also approved a companion diagnostic test from Myriad Genetics to be used to identify women most likely to benefit from the new medication.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast